I'm thrilled to sit down with Dr. Ivan Kairatov, a renowned expert in pediatric medicine with a focus on liver transplantation and patient-reported outcomes. With years of experience in research and innovation, Dr. Kairatov has been at the forefront of shifting how we understand children's
Imagine a silent epidemic affecting thousands of men each year, often undetected until it’s too late, with societal norms discouraging open conversations about personal health challenges, and prostate cancer standing as the most common cancer among men in the UK, with around 55,000 new cases
Wrist fractures, specifically distal radius fractures, rank among the most frequent orthopedic injuries, particularly impacting older adults who are prone to falls or trauma. These injuries often disrupt daily routines with persistent pain and limited mobility, making recovery a frustratingly slow
In the rapidly evolving landscape of biotechnology, few companies have captured the imagination of investors and industry watchers quite like Recursion Pharmaceuticals (NASDARXRX). Headquartered in Salt Lake City, Utah, this clinical-stage “TechBio” firm is at the forefront of a paradigm shift,
In a remarkable advancement that could alter the landscape of cancer care, researchers from University College London (UCL) and the University of Oxford have developed LungVax, the world’s first experimental vaccine aimed at preventing lung cancer. This pioneering initiative, now entering clinical
What happens when a beacon of hope for millions battling multiple sclerosis (MS) dims in a single clinical trial? In a field where breakthroughs are rare and desperately needed, Contineum Therapeutics, a San Diego-based biotech firm, has hit a significant roadblock with their lead drug, PIPE-307,
